{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:10:01Z","timestamp":1793239801454,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenkang 3-year project-Specialized clinical disease five new transformation project","award":["16CR3021A"],"award-info":[{"award-number":["16CR3021A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3563-5","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:03:03Z","timestamp":1565182983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III\u2013IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Jing","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"issue":"2","key":"3563_CR1","first-page":"133","volume":"21","author":"E Meijer","year":"2008","unstructured":"Meijer E, Jong PE, Peters DJ, Gansevoort RT. Better understanding of ADPKD results in potential new treatment options:ready for the cure. J Nephrol. 2008;21(2):133\u20138.","journal-title":"J Nephrol"},{"key":"3563_CR2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369:1287\u2013301.","journal-title":"Lancet"},{"issue":"2","key":"3563_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MNH.0b013e32835011a7","volume":"21","author":"TI Steinman","year":"2012","unstructured":"Steinman TI. Polycystic kidney disease: a 2011 update. Curr Opin Nephrol Hypertens. 2012;21(2):189\u201394.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3563_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1097\/00029330-200611020-00012","volume":"119","author":"B Dai","year":"2006","unstructured":"Dai B, Mei CL. Research on autosomal dominant polycystic kidney disease in China. Chin Med J (Engl). 2006;119:1915\u201324.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"3563_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a kidney Disease: improving global outcomes (KDIGO) controversies conference. Kid Int. 2015;88(1):17\u201327.","journal-title":"Kid Int"},{"issue":"4","key":"3563_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2215\/CJN.00060108","volume":"3","author":"AB Chapman","year":"2008","unstructured":"Chapman AB. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Cli J Am Soc Nephrol. 2008;3(4):1197.","journal-title":"Cli J Am Soc Nephrol"},{"issue":"3","key":"3563_CR7","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1111\/j.1523-1755.2005.00703.x","volume":"28","author":"VE Torres","year":"2005","unstructured":"Torres VE. Vasopressin antagonists in polycystic kidney disease. Kid Int. 2005;28(3):2405\u201318.","journal-title":"Kid Int"},{"issue":"2","key":"3563_CR8","first-page":"153","volume":"36","author":"R Lin","year":"2013","unstructured":"Lin R. Tolvaptan: a possible treatment for autosomal dominant polycystic kidney Disease. Ann Am Acad Pol Soc Sci. 2013;36(2):153\u201364.","journal-title":"Ann Am Acad Pol Soc Sci"},{"issue":"9","key":"3563_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363(9):820\u20139.","journal-title":"N Engl J Med"},{"key":"3563_CR10","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, et al. Tolvaptan in later-stage autosomal dominant polycystic kidney Disease. N Engl J Med. 2017;377:1930\u201342.","journal-title":"N Engl J Med"},{"key":"3563_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ndt\/gfy298","volume":"34","author":"P Gross","year":"2019","unstructured":"Gross P, Schirutschke H, Paliege A. Con: Tolvaptan for autosomal dominant polycystic kidney disease-do we know all the answers? Neph Dia Tran. 2019;34:35\u20137.","journal-title":"Neph Dia Tran"},{"key":"3563_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-019-1056-1","volume":"79","author":"HA Blair","year":"2019","unstructured":"Blair HA. Tolvaptan: a review in autosomal dominant polycystic kidney Disease. Drugs. 2019;79:303\u201313.","journal-title":"Drugs."},{"key":"3563_CR13","first-page":"13","volume-title":"GB\/T 16751.2\u20131997. Clinic terminology of traditional Chinese medical diagnosis and treatment\u2014syndromes","author":"State Bureau of Technical Supervision","year":"1997","unstructured":"State Bureau of Technical Supervision. GB\/T 16751.2\u20131997. Clinic terminology of traditional Chinese medical diagnosis and treatment\u2014syndromes. Beijing: Standards Press of China. 1997;2(7):13."},{"issue":"8","key":"3563_CR14","first-page":"682","volume":"17","author":"RL Li","year":"2016","unstructured":"Li RL, Du XR, Ding SY, Huang D, He LQ, Wang C, et al. Clinical observation of YNF on the treatment of ADPKD patients with spleen, kidney deficiency and blood stasis syndrome. Chin J Integr Tradit West Nephropathy. 2016;17(8):682\u20135.","journal-title":"Chin J Integr Tradit West Nephropathy"},{"key":"3563_CR15","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, Francisco ALMD, Jong PED, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150."},{"key":"3563_CR16","volume-title":"Guidelines for clinical research of Chinese medicine (new drug)","author":"YY Zheng","year":"2002","unstructured":"Zheng YY. Guidelines for clinical research of Chinese medicine (new drug). Beijing: Chinese Medicine and Science Publication House; 2002."},{"key":"3563_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13063-019-3234-6","volume":"20","author":"JU Sul","year":"2019","unstructured":"Sul JU, Kim MK, Leem J, Jo HG, Yoon SH, Kim J, et al. Efficacy and safety of gyejigachulbutang (Gui-Zhi-Jia-Shu-Fu-tang, Keishikajutsubuto, TJ-18) for knee pain in patients with degenerative knee osteoarthritis: a randomized, placebo-controlled, patient and assessor blinded clinical trial. Trials. 2019;20:140.","journal-title":"Trials."},{"issue":"4","key":"3563_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ki.2015.28","volume":"88","author":"KU Eckardt","year":"2015","unstructured":"Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2014a KDIGO consensus report. Kid Int. 2015;88(4):676\u201383.","journal-title":"Kid Int."},{"key":"3563_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2215\/CJN.09500911","volume":"7","author":"AB Chapman","year":"2012","unstructured":"Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2012;7:479\u201386.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3563_CR20","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/mrm.22278","volume":"63","author":"S Dambreville","year":"2010","unstructured":"Dambreville S, Chapman AB, Torres VE, King BF, Wallin AK, Frakes DH, et al. Renal arterial blood flow measurement by breath-held MRI: accuracy in phantom scans and reproducibility in healthy subjects. Magn Reson Med. 2010;63:940\u201350.","journal-title":"Magn Reson Med"},{"key":"3563_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"3563_CR22","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1523-1755.2004.00921.x","volume":"66","author":"ZH Bajwa","year":"2004","unstructured":"Bajwa ZH, Sial KA, Malik AB, Steinman TI, et al. Pain patterns in patients with polycystic kidney disease. Kidney Int. 2004;66:1561\u20139.","journal-title":"Kidney Int"},{"key":"3563_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/00002060-200110000-00001","volume":"80","author":"EW Johnson","year":"2001","unstructured":"Johnson EW. Visual analog scale (VAS). Am J Phys Med Rehabil. 2001;80:717.","journal-title":"Am J Phys Med Rehabil"},{"issue":"4","key":"3563_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.5056\/jnm.2011.17.4.402","volume":"17","author":"FY Chang","year":"2011","unstructured":"Chang FY, Lu CL, Luo JC, Chen TS, Chen MJ, Chang HJ. The evaluation of Otilonium bromide treatment in Asian patients with irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17(4):402\u201310.","journal-title":"J Neurogastroenterol Motil"},{"key":"3563_CR25","first-page":"498","volume":"6","author":"JD Gao","year":"2008","unstructured":"Gao JD, Wang C, Hou WG. Zheng Pingdong\u2019s experience in treating chronic renal failure. J Tradit Chi Med. 2008;6:498\u2013525.","journal-title":"J Tradit Chi Med"},{"key":"3563_CR26","first-page":"46","volume":"5","author":"AP Liu","year":"2014","unstructured":"Liu AP, Hao G. Parallel randomized controlled study of thyroid adenoma casual treatment of endometriosis. J Pract Tradit Chin Int Med. 2014;5:46\u20137.","journal-title":"J Pract Tradit Chin Int Med"},{"key":"3563_CR27","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/jssc.201700166","volume":"40","author":"H Zhu","year":"2017","unstructured":"Zhu H, Liu X, Zhu TT, Wang XL, Qin KM, Pei K, et al. UHPLC-MS\/MS method for the simultaneous quantitation of five anthraquinones and gallic acid in rat plasma after oral administration of prepared rhubarb decoction and its application to a pharmacokinetic study in normal and acute blood stasis rats. J Sep Sci. 2017;40:2382\u20139.","journal-title":"J Sep Sci"},{"key":"3563_CR28","first-page":"31","volume":"03","author":"CL Dang","year":"1996","unstructured":"Dang CL, Xin XN. Influence of Rhizoma sparganii on hemorrheology of rabbits. J Henan Med Uni. 1996;03:31\u20132.","journal-title":"J Henan Med Uni"},{"key":"3563_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.etap.2016.10.006","volume":"48","author":"X Chu","year":"2016","unstructured":"Chu X, Liu XJ, Qiu JM, Zeng XL, Bao HR, Shu J, et al. Environ Toxicol Pharmacol. 2016;48:76\u201384.","journal-title":"Environ Toxicol Pharmacol"},{"key":"3563_CR30","first-page":"3898957","volume":"2016","author":"JY Gao","year":"2016","unstructured":"Gao JY, Yang X, Yin WP. From traditional usage to pharmacological evidence: a systematic mini-review of spina gleditsiae. Evid Based Complement Alternat Med. 2016;2016:3898957.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"05","key":"3563_CR31","first-page":"365","volume":"36","author":"MH Liu","year":"2009","unstructured":"Liu MH, Huang XW, Xiao SH, Zhong L, Ren MP, Tian J. Effects of Extractive from Spina Gleditsiae (ESG) on Tumor Growth and Cytokines in Tumor-bearing Mice. Cancer Res Prevent Treat. 2009;36(05):365\u20137.","journal-title":"Cancer Res Prevent Treat"},{"key":"3563_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.etap.2010.09.004","volume":"31","author":"W Hu","year":"2011","unstructured":"Hu W, Han W, Huang C, Wang MH, et al. Protective effect of the methanolic extract from Duchesnea indica against oxidative stress in vitro and in vivo. Environ Toxicol Pharmacol. 2011;31:42\u201350.","journal-title":"Environ Toxicol Pharmacol"},{"key":"3563_CR33","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.biopha.2018.05.156","volume":"105","author":"R Arora","year":"2018","unstructured":"Arora R, Kumar R, Agarwal A, Reeta KH, Gupta YK. Comparison of three different extracts of Centella asiatica for anti-amnesic, antioxidant and anticholinergic activities: in vitro and in vivo study. Biomed Pharmacother. 2018;105:1344\u201352.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"3563_CR34","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.3390\/molecules22122101","volume":"22","author":"C Wang","year":"2017","unstructured":"Wang C, Zhou X, Wang Y, Wei D, Deng C, Xu X, et al. The antitumor constituents from Hedyotis Diffusa Willd. Molecules. 2017;22(12):2101.","journal-title":"Molecules."},{"issue":"3","key":"3563_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Internal Med. 2013;158(3):200\u20137.","journal-title":"Ann Internal Med"},{"key":"3563_CR36","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3563-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:28:28Z","timestamp":1596670108000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3563-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3563-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"9 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the ethics committee of each participating hospital. The international review board of Shuguang Hospital affiliated to Shanghai University of TCM approved the original protocol of this study on 26 August 2016 (2016-kykt-08) and the latest amendment was approved on 26 October 2016. It was approved by the research ethics committee of Shanghai Changzheng Hospital affiliated to the Second Military Medical University on 22 November 2017 (2017SL051). It was approved by the ethics committee of Shanghai Municipal Hospital affiliated to Shanghai University of TCM on 22 November 2016 (2016SHL-KYYS-35). All changes are included in this protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"481"}}